Current challenges in antimicrobial resistance and healthcare-associated infections: Role and organization of arhai

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue SUPPL.1, 2012, Pages

  Finch, Roger ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antibiotic resistance; Antimicrobial stewardship; Antiviral resistance; Clostridium difficile; Education; Government; Healthcare infections; MRSA; Surveillance; Veterinary infections

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; BIOCIDE; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; INTERFERON; PANTON VALENTINE LEUKOCIDIN;

ADVISORY COMMITTEE; ANIMAL HEALTH; ANIMAL WELFARE; ANTIBIOTIC RESISTANCE; ANTIVIRAL RESISTANCE; ARTICLE; BLOODSTREAM INFECTION; CAT; CHRONIC LIVER DISEASE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DENTIST; DISEASE COURSE; DOG; DRUG CLASSIFICATION; DRUG EFFICACY; GOVERNMENT; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH SURVEY; HEALTHCARE ASSOCIATED INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HERPES VIRUS; HOSPITAL INFORMATION SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFECTION CONTROL; LAW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NATIONAL HEALTH SERVICE; NONHUMAN; NURSE; PATIENT SAFETY; PHYSICIAN; PODIATRIST; PRESCRIPTION; PREVALENCE; SWINE; VETERINARY MEDICINE; VOCATIONAL EDUCATION; ZOONOSIS;

ADVISORY COMMITTEES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; GREAT BRITAIN; HEALTH EDUCATION; HEALTH PERSONNEL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PUBLIC HEALTH;

EID: 84864955280     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks204     Document Type: Article

References (30)

1. Department of Health. Advisory Committee on Antimicrobial Resistance and Healthcare-Associated infections. www.dh.gov.uk/ab/ARHAI/DH_ 087299 (24 February 2012, date last accessed).
2. Department of Health. ARHAI Newsletters. www.dh.gov.uk/ab/ARHAI/DH_108635 (24 February 2012, date last accessed).
3. Charani E, Cooke J, Holmes A. Antibiotic stewardship programmes- what's missing? J Antimicrob Chemother 2010; 65: 2275-7.
4. McNulty CAM, Francis N. Optimizing antibiotic prescribing in primary care settings in the UK: findings of a BSAC multi-disciplinary workshop 2009. J Antimicrob Chemother 2010; 65: 2278-84.
5. House of Lords Select Committee on Science and Technology. Resistance to antibiotics and other antimicrobial agents. London: Stationery Office, 1998.
6. House of Commons Hansard written answers. http://www.publications.parliament.uk/pa/cm200506/cmhansrd/vo060621/text/60621w0019.htm#06062210000921 (19 February 2012, date last accessed).
7. Department of Health. The Health and Social Care Act 2008: Code of Practice for health and adult social care on the prevention and control of infections and related guidance 2009. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_110288(19 February 2012, date last accessed).
8. General Medical Council. Tomorrow's Doctors online (2009). http://www.gmc-uk.org/education/undergraduate/tomorrows_doctors_2009.asp (19 February 2012, date last accessed).
9. Finch RG, Metlay JP, Davey PG et al. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 2004; 4: 44-53.
10. Do Bugs Need Drugs? http://www.dobugsneeddrugs.org/ (19 February 2012, date last accessed).
11. e-Bug Project. http://www.e-bug.eu (19 February 2012, date last accessed).
12. Grundmann H, Aires-de-Sousa M, Boyce J et al. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-5.
13. Ellington MJ, Hope R, Ganner M et al. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK? J Antimicrob Chemother 2007; 60: 402-5.
14. Health Protection Agency. Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1218699411960 (28 February 2012, date last accessed).
15. Nathwani D, Morgan M, Masterton RG et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008; 61: 976-94.
16. ARHAI tabled paper. MRSA in animals. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_095456.pdf (19 February 2012, date last accessed).
17. Voss A, Loeffen F, Bakker J et al. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 2005; 11: 1965-6.
18. Wulf MW, Markestein A, van der Linden FT et al. Staphylococcus aureus ST398 in a Dutch hospital, June 2007. Euro Surveill 2007; 28: pii: 8051.
19. NHS Purchasing and Supply Agency. Centre for Evidence-based Purchasing. Evaluation report, Clostridium difficile toxin detection assays. HPA, February 2009.
20. Revision of the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Summary of Responses to the Public consultation. http://ec.europa.eu/health/medical-devices/files/recast_docs_2008/ivd_pc_outcome_en.pdf (19 February 2012, date last accessed).
21. Wilcox MH, Fraise AP, Bradley CR et al. Sporicides for Clostridium difficile: the devil is in the detail. J Hosp Infect 2011; 77: 187-8.
22. Smyth ETM, McIlvenny G, Enstone JE et al. on behalf of the Hospital Infection Society Prevalence Survey Steering Group. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 2008; 69: 230-48.
23. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: a molecular, biological and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
24. The Joint Working Group of DARC and ARHAI. ESBLs-a threat to human and animal health? http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_132531 (16 February 2012, date last accessed).
25. Finch R, Hunter PA. Antibiotic resistance-action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005. J Antimicrob Chemother 2006; 58 Suppl S1: i3-22.
26. Swedish Predidency of the European Union. Conference innovative incentives for effective antibacterials. http://www.se2009.eu/en/meetings_news/2009/9/17/conference_innovative_incentives_for_effective_antibacterials.html (19 February 2012, date last accessed).
27. Re Act. The Global Need for Effective Antibiotics-Moving towards Concerted Action. http://www.reactgroup.org/what-we-do/react-activities/turning-a-new-page-on-antibiotics.html (19 February 2012, date last accessed).
28. Transatlantic Taskforce on Antimicrobial Resistance. Recommendations for future collaboration between the U.S. and EU. http://www.ecdc.europa.eu/en/activities/diseaseprogrammes/TATFAR/Documents/210911_TATFAR_Report.pdf (19 February 2012, date last accessed).
29. Finch R, Garner S. Increasing access to medicines. BMJ 2009; 338: b1397.
30. Department of Health. Chief Medical Officer's Annual Report for 2008: On the state of public health. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_096231.pdf (19 February 2012, date last accessed).